Jason D. Smith - Jan 31, 2024 Form 4/A Insider Report for UroGen Pharma Ltd. (URGN)

Role
General Counsel
Signature
/s/ Jason D. Smith, Attorney-in-Fact
Stock symbol
URGN
Transactions as of
Jan 31, 2024
Transactions value $
-$78,790
Form type
4/A
Date filed
2/5/2024, 09:16 PM
Date Of Original Report
Feb 2, 2024
Previous filing
Sep 8, 2023
Next filing
Sep 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction URGN Ordinary Shares Sale -$6.58K -417 -2.17% $15.78 18.8K Feb 1, 2024 Direct F1, F2
transaction URGN Ordinary Shares Sale -$19.7K -1.25K -5.85% $15.78 20.1K Feb 1, 2024 Direct F1, F2
transaction URGN Ordinary Shares Sale -$52.5K -3.33K -12.44% $15.78 23.4K Feb 1, 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This amendment corrects and restates the date of sale reported in the original Form 4 filed on February 2, 2024.
F2 This amendment corrects and restates the sales price reported in the original Form 4 filed on February 2, 2024.